Yes. It delays implementation of those technologies.
As important is the MRL issue for crop protection products. Again, it comes down to synchronization in the world markets of how the approvals are in place. One country can have an approval; another one doesn't. As a commodity market in Canada, we sell a blended stream, so that boat could be going to Japan or to China. It is critical that our MRL approvals, our biotech approvals, are in place for all of our markets at the same time. Having a mechanism to get those approvals in a region, as opposed to individual countries, significantly benefits us in our ability to get those products and traits to market, but also in the costs that the farmers absorb because of the development time and paperwork that is associated with getting those approvals in every single market.